NCT04783168

Brief Summary

This clinical trial evaluates the relationship between walking and sleeping habits and surgical outcomes in patients with lung cancer. Early walking after surgery is associated with decreased or less severe complications. Learning about how much patients walk may be important in improving outcomes after surgery. Information gained from this trial may help researchers develop interventions to improve outcomes after surgery and improve overall quality of life after surgery in patients with lung cancer.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
9mo left

Started Nov 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Nov 2020Feb 2027

Study Start

First participant enrolled

November 30, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 3, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 5, 2021

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 2, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 2, 2027

Last Updated

April 16, 2026

Status Verified

April 1, 2026

Enrollment Period

6.2 years

First QC Date

February 3, 2021

Last Update Submit

April 13, 2026

Conditions

Keywords

WearabledevicefitnesstrackerFitbitambulationlung cancersurgicalrecovery

Outcome Measures

Primary Outcomes (1)

  • Clavien-Dindo postoperative morbidity (POM) score

    Two Bayesian probability and inferential models will be utilized: * Model 1: Inferential goals: Probability that POM score in the control arm is greater than F0 or FB arm: mean and 95% Credible Interval * Model 2: Baseline covariates adjusted analysis of model 1 * Performance status * FEV1 * Age * Open vs. Minimally invasive (0 is best, 5 is worst.) 0 - No postoperative complications 1. - Minor complication resolved without intervention 2. - complication requiring pharmaceutical intervention 3. - complication requiring surgical, endoscopic or radiological intervention, 4. - life-threatening complication requiring intensive care 5. - complication leading to the patient's death.

    Up to 30 days after surgery

Secondary Outcomes (7)

  • Differences in steps regained at each postoperative day (Fitbit only arm [F0] and Fitbit integration arm [FB])

    Up to 30 days after surgery

  • Change in quality of life

    Baseline to 30 days after surgery

  • Hospital length of stay

    Up to 30 days after surgery

  • Hospital readmission rate for lung surgery related events

    Up to 30 days after surgery

  • Return of bowel function

    Up to 30 days after surgery

  • +2 more secondary outcomes

Study Arms (3)

Arm I (usual care)

ACTIVE COMPARATOR

Patients receive usual care consisting of the clinician educating the patient on the importance of increasing exercise activity in the preoperative period and early ambulation in the postoperative setting.

Other: Best PracticeOther: Quality-of-Life AssessmentOther: Questionnaire Administration

Arm II (usual care, Fitbit)

ACTIVE COMPARATOR

Patients receive usual care consisting of the clinician educating the patient on the importance of increasing exercise activity in the preoperative period and early ambulation in the postoperative setting. Patients also receive a Fitbit to monitor step count

Other: Best PracticeOther: Medical Device Usage and EvaluationOther: Quality-of-Life AssessmentOther: Questionnaire Administration

Arm III (usual care, Fitbit, Fitbit app)

EXPERIMENTAL

Patients receive usual care consisting of the clinician educating the patient on the importance of increasing exercise activity in the preoperative period and walking in the postoperative setting. Patients also receive a Fitbit device, install and use the Fitbit app on a smartphone. Postoperative step goals are as follows: Postoperative day (POD) 1: 25% of baseline. Subsequent days will be increased by 10% until patient reaches baseline daily step number. Five automatic daily reminders (delivered by the Fitbit Inspire HR\^TM device itself) to meet a minimum of 250 steps an hour. Postoperatively, patients will be invited to participate in a private group with a leaderboard that consists of step numbers of other participants in the study in an anonymous fashion.

Other: Best PracticeOther: Health Promotion and EducationOther: Medical Device Usage and EvaluationOther: Quality-of-Life AssessmentOther: Questionnaire Administration

Interventions

Receive usual care

Also known as: standard of care, standard therapy
Arm I (usual care)Arm II (usual care, Fitbit)Arm III (usual care, Fitbit, Fitbit app)

Install and use Fitbit app

Arm III (usual care, Fitbit, Fitbit app)

Use Fitbit to monitor step count

Arm II (usual care, Fitbit)Arm III (usual care, Fitbit, Fitbit app)

Ancillary studies

Also known as: Quality of Life Assessment
Arm I (usual care)Arm II (usual care, Fitbit)Arm III (usual care, Fitbit, Fitbit app)

Ancillary studies

Arm I (usual care)Arm II (usual care, Fitbit)Arm III (usual care, Fitbit, Fitbit app)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • English speaking
  • Ambulatory preoperatively
  • Patients undergoing at least a lobectomy
  • Must own a smart phone and be willing to install the Fitbit application (App)
  • Adequate internet connection via wifi or wireless network connection with smartphone
  • Patients who are not already using a wearable device to track daily steps

You may not qualify if:

  • Medical, psychiatric, cognitive or other conditions that compromise the patient's ability to understand the patient information, to give informed consent, to comply with the study protocol or to complete the study.
  • Cannot maintain activity monitor in place at the time of consent
  • Pregnant patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

RECRUITING

Related Links

MeSH Terms

Conditions

Lung Neoplasms

Interventions

Practice Guidelines as TopicStandard of CareHealth PromotionEducational Status

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Guidelines as TopicQuality Assurance, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and EvaluationQuality Indicators, Health CareHealth EducationPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesSocioeconomic FactorsPopulation Characteristics

Study Officials

  • Garrett L Walsh

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Garrett L Walsh

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 3, 2021

First Posted

March 5, 2021

Study Start

November 30, 2020

Primary Completion (Estimated)

February 2, 2027

Study Completion (Estimated)

February 2, 2027

Last Updated

April 16, 2026

Record last verified: 2026-04

Locations